Chandra L. Theesfeld

Chandra L. Theesfeld

Auto-generated profile, based on publicly available information

Chandra L. Theesfeld

Princeton Precision Health, Princeton University, Princeton, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2018 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
JZJian Zhou
Jian Zhou
CTChandra L. Theesfeld
Chandra L. Theesfeld
KYKevin Yao
Kevin Yao
KCKathleen M. Chen
Kathleen M. Chen
AWAaron K. Wong
Aaron K. Wong
OTOlga G. Troyanskaya
Olga G. Troyanskaya

1 December 2020 in Molecular Cell
Verified
Journal Article
Closed access
CIChristiane Iserman
Christiane Iserman
CRChristine A. Roden
Christine A. Roden
MBMark A. Boerneke
Mark A. Boerneke
RSRachel S.G. Sealfon
Rachel S.G. Sealfon
GMGrace A. McLaughlin
Grace A. McLaughlin
AGAmy S. Gladfelter
Amy S. Gladfelter

9 July 2025 in Nature Genetics
Verified
Journal Article
Open access
PDF file
ALAviya Litman
Aviya Litman
NSNatalie Sauerwald
Natalie Sauerwald
LSLeeAnne Green Snyder
LeeAnne Green Snyder
JFJennifer Foss-Feig
Jennifer Foss-Feig
CPChristopher Y. Park
Christopher Y. Park
OTOlga G. Troyanskaya
Olga G. Troyanskaya
Unraveling the phenotypic and genetic complexity of autism is extremely challenging yet critical for understanding the biology, inheritance, trajectory and clinical manifestations of the many forms of the condition. Using a generative mixture modeling approach, we leverage broad phenotypic data from a large cohort with matched genetics to identify robust, clinically relevant classes of autism and their patterns of core, associated and co-occurring traits, which we further validate and replicate in an independent cohort. We demonstrate that phenotypic and clinical outcomes correspond to genetic and molecular programs of common, de novo and inherited variation and further characterize distinct pathways disrupted by the sets of mutations in each class. Remarkably, we discover that class-specific differences in the developmental timing of affected genes align with clinical outcome differences. These analyses demonstrate the phenotypic complexity of children with autism, identify genetic programs underlying their heterogeneity, and suggest specific biological dysregulation patterns and mechanistic hypotheses.

23 December 2020 in Genome Research
Verified
Journal Article
Open access
PDF file
KGKiley Graim
Kiley Graim
DGDmitriy Gorenshteyn
Dmitriy Gorenshteyn
DRDavid G. Robinson
David G. Robinson
NCNicholas J. Carriero
Nicholas J. Carriero
JCJames A. Cahill
James A. Cahill
OTOlga G. Troyanskaya
Olga G. Troyanskaya
Understanding the changes in diverse molecular pathways underlying the development of breast tumors is critical for improving diagnosis, treatment, and drug development. Here, we used RNA-profiling of canine mammary tumors (CMTs) coupled with a robust analysis framework to model molecular changes in human breast cancer. Our study leveraged a key advantage of the canine model, the frequent presence of multiple naturally occurring tumors at diagnosis, thus providing samples spanning normal tissue and benign and malignant tumors from each patient. We showed human breast cancer signals, at both expression and mutation level, are evident in CMTs. Profiling multiple tumors per patient enabled by the CMT model allowed us to resolve statistically robust transcription patterns and biological pathways specific to malignant tumors versus those arising in benign tumors or shared with normal tissues. We showed that multiple histological samples per patient is necessary to effectively capture these progression-related signatures, and that carcinoma-specific signatures are predictive of survival for human breast cancer patients. To catalyze and support similar analyses and use of the CMT model by other biomedical researchers, we provide FREYA, a robust data processing pipeline and statistical analyses framework.

25 July 2023 in Nature Computational Science
Verified
Journal Article
Open access
PDF file
XCXi Chen
Xi Chen
YWYuan Wang
Yuan Wang
ACAntonio Cappuccio
Antonio Cappuccio
WCWan-Sze Cheng
Wan-Sze Cheng
FZFrederique Ruf Zamojski
Frederique Ruf Zamojski
SSStuart C. Sealfon
Stuart C. Sealfon
Resolving chromatin-remodeling-linked gene expression changes at cell-type resolution is important for understanding disease states. Here we describe MAGICAL (Multiome Accessibility Gene Integration Calling and Looping), a hierarchical Bayesian approach that leverages paired single-cell RNA sequencing and single-cell transposase-accessible chromatin sequencing from different conditions to map disease-associated transcription factors, chromatin sites, and genes as regulatory circuits. By simultaneously modeling signal variation across cells and conditions in both omics data types, MAGICAL achieved high accuracy on circuit inference. We applied MAGICAL to study Staphylococcus aureus sepsis from peripheral blood mononuclear single-cell data that we generated from subjects with bloodstream infection and uninfected controls. MAGICAL identified sepsis-associated regulatory circuits predominantly in CD14 monocytes, known to be activated by bacterial sepsis. We addressed the challenging problem of distinguishing host regulatory circuit responses to methicillin-resistant and methicillin-susceptible S. aureus infections. Although differential expression analysis failed to show predictive value, MAGICAL identified epigenetic circuit biomarkers that distinguished methicillin-resistant from methicillin-susceptible S. aureus infections.

1 February 2019 in Cell Systems
Verified
Journal Article
Closed access
YLYoung-Suk Lee
Young-Suk Lee
AKArjun Krishnan
Arjun Krishnan
RORose Oughtred
Rose Oughtred
JRJennifer Rust
Jennifer Rust
CCChristie S. Chang
Christie S. Chang
OTOlga G. Troyanskaya
Olga G. Troyanskaya